As shown in Fig. 1C, the mRNA level of CAMK2N1 was significantly reduced in prostate cancer tissues compared to normal prostate, which is consistent with the reduced protein expression in prostate cancer cells. This evidence concerns the gene CAMK2N1 and prostate carcinoma.